The Asian Scientist 100
Can Li
Institution
University of Hong Kong
Country
Hong Kong
Field
Engineering
Li is a recipient of the 2023 Croucher Tak Wah Mak Innovation Award for his research exploring the limitations of digital computers in performing tasks accomplished by the human brain, including recognising faces, reasoning based on vague information, and learning from experience.
(Photo: University of Hong Kong)
AWARDS
- 2023 Croucher Tak Wah Mak Innovation Award
Related articles
Astellas’ Prostate Cancer Drug Available In Japan
The androgen receptor signaling inhibitor XTANDI® has been approved for castration-resistant prostate cancer in Japan.
Aharonov-Bohm Explains Quantum Tunneling
Scientists from Japan have demonstrated that an important physical effect accounts for the dynamics of a quantum tunneling system.
South Asia Lacks Predictive Model For Aerosols
South Asia requires a more accurate model of aerosol behavior in the region for better predictions of the spread of disease and flight disruptions, scientists say.
Teaching Robots Teamwork
Researchers at Peking University have devised new strategies to enable mobile robots to collaboratively form and maintain a circle arrangement.
Breeding Fungus Resistant Oilseed Varities
Scientists have identified strains of oilseed plants that are resistant to the devastating fungal pathogen Sclerotinia.
NTU Launches US$24 Million 3D Printing Center
The opening of the NTU Additive Manufacturing Center (NAMC) also saw the launch of a S$5 million collaboration with SLM Solutions and an international scientific conference.
Averting A Post-Antibiotic Era In Asia-Pac
Research into new classes of antibiotics and stronger regulation are needed to prevent the slide into a post-antibiotic era, Crispin Maslog says.
Self-Assembling Peptide Nanogel For Burns
IBN's ultrashort peptide-based gel mimics extracellular matrix to promote superior skin regeneration.
Agenix Sells HBV Drug To Cinkate For USD$2 Million
With the sale of its patented hepatitis drug AGX-1009 to Cintake, Agenix has exited all operations in China.